Home › Bahrain › HEXAXIM

HEXAXIM SUSPENSION FOR INJECTION

INACTIVATED POLIOVIRUS (TYPE 1 (MAHONEY) 40D + TYPE 2 (MEF-1) 8D + TYPE 3 (SAUKETT) 32D) + HEPATITIS B SURFACE ANTIGEN 10MCG + DIPHTHERIA TOXOID NLT 20IU + TETANUS TOXOID NLT 40IU + BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25MCG & FILAMENTOUS HAEMAGGLUTININ 25MCG) + HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE) 12MCG CONJUGATED TO TETANUS PROTEIN (22-36MCG). · Bahrain

Listed price in Bahrain

18.57 BHD

Generic name: INACTIVATED POLIOVIRUS (TYPE 1 (MAHONEY) 40D + TYPE 2 (MEF-1) 8D + TYPE 3 (SAUKETT) 32D) + HEPATITIS B SURFACE ANTIGEN 10MCG + DIPHTHERIA TOXOID NLT 20IU + TETANUS TOXOID NLT 40IU + BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25MCG & FILAMENTOUS HAEMAGGLUTININ 25MCG) + HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE) 12MCG CONJUGATED TO TETANUS PROTEIN (22-36MCG).
Dosage form: SUSPENSION FOR INJECTION
Pack: 1 (0.5ML) + 2

About INACTIVATED POLIOVIRUS (TYPE 1 (MAHONEY) 40D + TYPE 2 (MEF-1) 8D + TYPE 3 (SAUKETT) 32D) + HEPATITIS B SURFACE ANTIGEN 10MCG + DIPHTHERIA TOXOID NLT 20IU + TETANUS TOXOID NLT 40IU + BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25MCG & FILAMENTOUS HAEMAGGLUTININ 25MCG) + HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE) 12MCG CONJUGATED TO TETANUS PROTEIN (22-36MCG).

Combination childhood vaccine

Used for

Prevents diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b disease.

Usual adult dose

Not routinely used in adults; it is intended for infant and young-child vaccination.

Usual dose in children

One intramuscular dose per visit, given as a three-dose primary series; a booster may follow, according to the national schedule and product guidance.

Common side effects

Pain, redness, or swelling at the injection site
Fever, irritability, crying, or sleepiness
Reduced appetite or vomiting
Uncommon: allergic reaction or prolonged seizure

Important warnings

Do not give after a severe allergic reaction to a previous dose or vaccine component.
Do not give to someone with encephalopathy of unknown cause after a pertussis-containing vaccine.
Defer during severe acute illness; minor illness is generally not a reason to delay.
Seek urgent care for breathing difficulty, facial swelling, or collapse after vaccination.

Pregnancy

Not indicated for pregnancy; safety data are limited.

Breastfeeding

Not indicated for breastfeeding adults; it is a childhood vaccine.

Interactions

Immunosuppressive treatment may reduce the immune response.
May be given with other routine vaccines at separate injection sites.

AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.

Alternatives with INACTIVATED POLIOVIRUS (TYPE 1 (MAHONEY) 40D + TYPE 2 (MEF-1) 8D + TYPE 3 (SAUKETT) 32D) + HEPATITIS B SURFACE ANTIGEN 10MCG + DIPHTHERIA TOXOID NLT 20IU + TETANUS TOXOID NLT 40IU + BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25MCG & FILAMENTOUS HAEMAGGLUTININ 25MCG) + HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE) 12MCG CONJUGATED TO TETANUS PROTEIN (22-36MCG). in Bahrain

Same active ingredient: same strength and form first, then by listed price. Pack sizes may differ; ask your pharmacist before switching.

HEXAXIM
INACTIVATED POLIOVIRUS (TYPE 1 (MAHONEY) 40D + TYPE 2 (MEF-1) 8D + TYPE 3 (SAUKETT) 32D) + HEPATITIS B SURFACE ANTIGEN 10MCG + DIPHTHERIA TOXOID NLT 20IU + TETANUS TOXOID NLT 40IU + BORDETELLA PERTUSSIS ANTIGENS (PERTUSSIS TOXOID 25MCG & FILAMENTOUS HAEMAGGLUTININ 25MCG) + HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE) 12MCG CONJUGATED TO TETANUS PROTEIN (22-36MCG). · SUSPENSION FOR INJECTION · 1 (0.5ML) + 2

18.57 BHD